Development of a CRISPR/Cas12a-based fluorescent detection method of Senecavirus A
- PMID: 38877537
- PMCID: PMC11179212
- DOI: 10.1186/s12917-024-04116-6
Development of a CRISPR/Cas12a-based fluorescent detection method of Senecavirus A
Abstract
Background: Senecavirus A (SVA), identified in 2002, is known to cause porcine idiopathic vesicular disease (PIVD), which presents with symptoms resembling other vesicular diseases. This similarity complicates field diagnosis. Conventional molecular diagnostic techniques are limited by their cost, sensitivity, and requirement for complicated instrumentation. Therefore, developing an effective and accurate diagnostic method is crucial for timely identification and isolation of affected pigs, thereby preventing further disease spread.
Methods: In this study, we developed a highly-specific and ultra-sensitive SVA detection method powered by CRISPR/Cas12a. To enhance the availability in laboratories with varied equipment conditions, microplate reader and ultraviolet light transilluminator were introduced. Moreover, PCR amplification has also been incorporated into this method to improve sensitivity. The specificity and sensitivity of this method were determined following the preparation of the recombinant Cas12a protein and optimization of the CRISPR/Cas12a-based trans-cleavage system.
Results: The method demonstrated no cross-reactivity with ten kinds of viruses of swine. The minimum template concentration required to activate substantial trans-cleavage activity was determined to be 106 copies/µL of SVA templates. However, when PCR amplification was incorporated, the method achieved a detection limit of one copy of SVA templates per reaction. It also exhibited 100% accuracy in simulated sample testing. The complete testing process does not exceed three hours.
Conclusions: Importantly, this method utilizes standard laboratory equipment, making it accessible for use in resource-limited settings and facilitating widespread and ultra-sensitive screening during epidemics. Overall, the development of this method not only broadens the array of tools available for detecting SVA but also holds significant promise for controlling the spread of PIVD.
Keywords: CRISPR/Cas12a; PIVD; Rapid diagnosis; Senecavirus A; Ultra-sensitivity.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
A rapid and visual detection assay for Senecavirus A based on recombinase-aided amplification and lateral flow dipstick.Front Cell Infect Microbiol. 2024 Oct 23;14:1474676. doi: 10.3389/fcimb.2024.1474676. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39507945 Free PMC article.
-
Development of a novel reverse transcription droplet digital PCR assay for the sensitive detection of Senecavirus A.Transbound Emerg Dis. 2019 Jan;66(1):517-525. doi: 10.1111/tbed.13056. Epub 2018 Nov 26. Transbound Emerg Dis. 2019. PMID: 30375741
-
Development of a real time loop-mediated isothermal amplification method for detection of Senecavirus A.J Virol Methods. 2018 Nov;261:98-103. doi: 10.1016/j.jviromet.2018.08.005. Epub 2018 Aug 7. J Virol Methods. 2018. PMID: 30096349
-
Comprehensive review on immunopathogenesis, diagnostic and epidemiology of Senecavirus A.Virus Res. 2020 Sep;286:198038. doi: 10.1016/j.virusres.2020.198038. Epub 2020 May 30. Virus Res. 2020. PMID: 32479975 Review.
-
Senecavirus A.Vet Pathol. 2017 Jan;54(1):11-21. doi: 10.1177/0300985816653990. Epub 2016 Jul 11. Vet Pathol. 2017. PMID: 27371541 Review.
References
-
- Reddy PS, Burroughs KD, Hales LM, Ganesh S, Jones BH, Idamakanti N, Hay C, Li SS, Skele KL, Vasko AJ, Yang J, Watkins DN, Rudin CM, Hallenbeck PL. Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers. J Natl Cancer Inst. 2007;99(21):1623–33. doi: 10.1093/jnci/djm198. - DOI - PMC - PubMed
-
- Rudin CM, Poirier JT, Senzer NN, Stephenson J, Jr, Loesch D, Burroughs KD, Reddy PS, Hann CL, Hallenbeck PL. Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features. Clin Cancer Res. 2011;17(4):888–95. doi: 10.1158/1078-0432.CCR-10-1706. - DOI - PMC - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
- 2022A1272/Natural Science Foundation of Ningxia Province
- 2023KLA004/Xinjiang Key Laboratory of Electronic Information Materials and Devices
- 2023KLA004/Xinjiang Key Laboratory of Electronic Information Materials and Devices
- 2023KLA004/Xinjiang Key Laboratory of Electronic Information Materials and Devices
- 2023KLA004/Xinjiang Key Laboratory of Electronic Information Materials and Devices
LinkOut - more resources
Full Text Sources